Company Shares of Amedica Corporation (NASDAQ:AMDA) Drops by -33.46%

Amedica Corporation (NASDAQ:AMDA) : During the past 4 weeks, traders have been relatively bearish on Amedica Corporation (NASDAQ:AMDA), hence the stock is down -34.52% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -34.3% relative to the S&P 500. The 4-week change in the price of the stock is -33.46% and the stock has fallen -33.46% in the past 1 week.

The company shares have dropped -90.22% from its 1 Year high price. On Jul 24, 2015, the shares registered one year high at $12.59 and the one year low was seen on Jul 6, 2016. The 50-Day Moving Average price is $1.31 and the 200 Day Moving Average price is recorded at $1.74.

The stock has recorded a 20-day Moving Average of 30.97% and the 50-Day Moving Average is 35.34%.


Amedica Corporation (NASDAQ:AMDA): stock turned positive on Friday. Though the stock opened at $0.88, the bulls momentum made the stock top out at $0.91 level for the day. The stock recorded a low of $0.87 and closed the trading day at $0.885, in the green by 0.53%. The total traded volume for the day was 902,967. The stock had closed at $0.8803 in the previous days trading.

In an insider trading activity, Lombardi Ty, officer (VP Finance) of Amedica Corp, executed a transaction worth $10,000 on September 10, 2015. A total of 25,000 shares were purchased at an average price of $0.4. The Insider information was divulged by the Securities and Exchange Commission in a Form 4 filing. The information is based on open market trades at the market prices.Option exercises are not covered.

Amedica Corporation is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer focused on using its silicon nitride technology platform to develop, manufacture and sell a range of medical devices. The Company markets spinal fusion products and are developing products for use in total hip and knee joint replacements. The Company markets its Valeo family of silicon nitride interbody spinal fusion devices in the United States and Europe for use in the cervical and thoracolumbar areas of the spine. The Companys Valeo interbody spinal fusion devices include Anterior Lumbar, Posterior Lumbar, Oblique Lumbar, Transforaminal Lumbar, Cervical and Corpectomy. In addition to its silicon nitride-based spinal fusion products, the Company markets a line of non-silicon nitride spinal fusion products, which allows it to provide surgeons and hospitals with a range of products.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.